Oxymetholone therapy in aplastic and other refractory anaemias.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D000756:Anemia, Sideroblastic / Q000150:complications / Q000188:drug therapy*; D001772:Blood Cell Count; D001792:Blood Platelets; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010110:Oxymetholone / Q000009:adverse effects / Q000627:therapeutic use*; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy; D013739:Testosterone / Q000627:therapeutic use
D006454:Hemoglobins; D013739:Testosterone; D010110:Oxymetholone